This report from MMJ Daily, published on 22 May 2026.
BioCann operates what it says is the largest commercial indoor cannabis facility in South Africa, shipping flower to Germany, the UK, and Australia from seven licensed hectares on a 100-hectare farm in Limpopo province, with EU-GMP equipment already imported and an inspection pending.
The company holds GACP status under SAHPRA licensing, with Control Union running third-party oversight. Woody Chammas, CEO and co-founder of BioCann, says GMP certification is already in motion. “We are GACP now, and the next stage is GMP.
“We are GACP now, and the next stage is GMP. What has been done is an entire remodeling and renovation of our processing facility, new installation of HVAC units, internal renovation of all the rooms and all the areas, basically rebuilt from the inside. All that remains is the process validation, which will take us one step closer to our GMP compliance,”
The Genetics Have a Story Behind Them
Genetics come from Segra International, a Canadian breeder whose varieties carry Health Canada registration and a digital traceability fingerprint running from tissue culture through testing. Woody says the choice was deliberate and goes back to day one.
“They have the digital fingerprint of traceability of genetics, it’s registered under Health Canada. Their genetics have a story behind them,” he says. “Integrity comes from the tissue lab and comes with a lot of testing, and we can import it into South Africa. We are strategically working with them since the beginning.”
Shaq Badat, General Manager at BioCann, says the facility’s indoor environment is where the genetics are actually realized. Bluntly put, environmental control determines how much of a variety’s genetic ceiling a crop ever reaches. “Any cultivator that understands genetics knows expression has two inputs: genetics potential and the environment that takes that potential out.
Gene expression is dictated by the environment,” he says. “When Segra would give the same genetics to a facility in a specific cultivation system, it would be night and day compared to the expression we get at BioCann due to the environmental controls we have. That’s what sets us apart.”
COAs are how Shaq backs the claim. Terpene and cannabinoid profiles are the metric BioCann points to as proof that its environmental protocols deliver. “We pride ourselves on getting genetics with high potential, but the story doesn’t end there. With our environmental control we get the best out of those genetics, proven with our testing and COAs. Highest terpenes, highest cannabinoids, that’s something we are very proud of doing.”
The Right Picks
Variety selection runs across cannabinoid and terpene profile first, then flower morphology, shape and symmetry, cultivation habit, yield potential, and processability.
“For us number one is the cannabinoid and terpene profile. What’s the THC potential, what’s the terpene potential,” Shaq says. “What is the flower expression? What’s the morphology of the flower, the shape, the symmetry. And we take it a step further: what is its cultivation habit, what’s the yield potential, the processing potential, is it something difficult or easy to process. On the quality side, it’s a measure of both quality and quantity capabilities.”
“Our primary focus is premium quality indoor flower, that’s our differentiating production line in the market space right now,” Shaq says. “Later on we’ll diversify our portfolio into strain-specific extracts. If we have strain X, you will also find it in extract form. But flower is our main focus right now.”
#
